πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,756 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 6395712

Sensitization of HER-2/neu overexpressing cancer cells to chemotherapy

The Board of Regents of the University of Texas System Β· Granted Tue May 28 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 23 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6391049

Solid biodegradable device for use in tissue repair

The Board of Regents of the University of Texas System Β· Granted Tue May 21 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 16 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6375930

Membrane incorporation of texaphyrins

The Board of Regents of the University of Texas System Β· Granted Tue Apr 23 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6372957

Transgenic mouse comprising a MEF2 binding site operatively linked to an indicator gene an

The Board of Regents of the University of Texas System Β· Granted Tue Apr 16 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6368596

Compositions and methods for homoconjugates of antibodies which induce growth arrest or ap

The Board of Regents of the University of Texas System Β· Granted Tue Apr 09 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6362322

Conversion of a watson-crick DNA to a hoogsteen-paired duplex

The Board of Regents of the University of Texas System Β· Granted Tue Mar 26 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6362200

Antitumor dibenzofluorene derivatives

The Board of Regents of the University of Texas System Β· Granted Tue Mar 26 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6355619

Peptide tumor cell growth inhibitors

The Board of Regents of the University of Texas System Β· Granted Tue Mar 12 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6350729

Inhibition of nitric oxide-mediated hypotension and septic shock with iron-containing hemo

The Board of Regents of the University of Texas System Β· Granted Tue Feb 26 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 21 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6346607

APAF-1 an activator of caspase-3

The Board of Regents of the University of Texas System Β· Granted Tue Feb 12 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6342484

Method and compositions for promotion of wound treatment

The Board of Regents of the University of Texas System Β· Granted Tue Jan 29 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 24 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6342221

Antibody conjugate compositions for selectively inhibiting VEGF

The Board of Regents of the University of Texas System Β· Granted Tue Jan 29 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 24 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6342219

Antibody compositions for selectively inhibiting VEGF

The Board of Regents of the University of Texas System Β· Granted Tue Jan 29 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 24 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6342216

Therapy of cancer by insect cells containing recombinant baculovirus encoding genes

The Board of Regents of the University of Texas System Β· Granted Tue Jan 29 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 24 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6337206

Nucleic acid encoding mouse galanin receptor (GALR2)

The Board of Regents of the University of Texas System Β· Granted Tue Jan 08 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 03 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6333313

Clinical use of oxytocin alone or in combination to treat bone disorders

The Board of Regents of the University of Texas System Β· Granted Tue Dec 25 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6331284

P202 is a tumor suppressor

The Board of Regents of the University of Texas System Β· Granted Tue Dec 18 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6326356

Suppression of neu overexpression using a mini-E1A gene

The Board of Regents of the University of Texas System Β· Granted Tue Dec 04 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6323226

Treatment of heart disease with cox-2 inhibitors

The Board of Regents of the University of Texas System Β· Granted Tue Nov 27 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6320027

Nucleotide sequence of the nucleocapsid gene of oropouche virus

The Board of Regents of the University of Texas Β· Granted Tue Nov 20 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6313155

Composition and method for treating macular disorders

The Board of Regents of the University of Texas System Β· Granted Tue Nov 06 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6312694

Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids

The Board of Regents of the University of Texas System Β· Granted Tue Nov 06 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6310190

USPA1 and USPA2 antigens of Moraxella catarrhalis

The Board of Regents of the University of Texas Β· Granted Tue Oct 30 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6309854

Polynucleotides encoding ligands of the neuropeptide receptor HFGAN72

The Board of Regents of the University of Texas System Β· Granted Tue Oct 30 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired